Abnormalities in Non-Cholinergic Neurotransmitter Systems in Alzheimer’s Disease
Author:
Dewar D.,McCulloch J.
Reference203 articles.
1. Akiyama, H., McGeer, P.L., Itagaki, S. et al. (1989) Loss of glutaminase-positive cortical neurons in Alzheimer’s disease. Neurochem. Res., 14, 353–8. 2. Alhainen, K., Sirviö, J., Helkala, E.-L. et al. (1991) Somatostatin and cognitive functions in Alzheimer’s disease — the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine. Neurosci. Lett., 130, 46–8. 3. Arai, H., Kosaka, K. and Iizuka, R. (1984) Changes of biogenic amines and their metabolites in post mortem brain from patients with Alzheimer type dementia. J. Neurochem., 43, 388–93. 4. Arai, H., Kobayashi, K., Ichimiya, Y. et al. (1985) Free amino acids in post-mortem cerebral cortices from patients with Alzheimer-type dementia. Neurosci. Res., 2, 486–90. 5. Armstrong, D.M. and Terry, R.D. (1985) Substance P immunoreactivity within neuritic plaques. Neurosci. Lett., 58, 139–44.
|
|